These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32584818)

  • 41. Venezuelan Equine Encephalitis Virus Induces Apoptosis through the Unfolded Protein Response Activation of EGR1.
    Baer A; Lundberg L; Swales D; Waybright N; Pinkham C; Dinman JD; Jacobs JL; Kehn-Hall K
    J Virol; 2016 Jan; 90(7):3558-72. PubMed ID: 26792742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dissecting the Role of E2 Protein Domains in Alphavirus Pathogenicity.
    Weger-Lucarelli J; Aliota MT; Wlodarchak N; Kamlangdee A; Swanson R; Osorio JE
    J Virol; 2015 Dec; 90(5):2418-33. PubMed ID: 26676771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eastern equine encephalitis virus in mice II: pathogenesis is dependent on route of exposure.
    Honnold SP; Mossel EC; Bakken RR; Lind CM; Cohen JW; Eccleston LT; Spurgers KB; Erwin-Cohen R; Glass PJ; Maheshwari RK
    Virol J; 2015 Sep; 12():154. PubMed ID: 26423229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endemic and Epidemic Human Alphavirus Infections in Eastern Panama: An Analysis of Population-Based Cross-Sectional Surveys.
    Carrera JP; Cucunubá ZM; Neira K; Lambert B; Pittí Y; Liscano J; Garzón JL; Beltran D; Collado-Mariscal L; Saenz L; Sosa N; Rodriguez-Guzman LD; González P; Lescano AG; Pereyra-Elías R; Valderrama A; Weaver SC; Vittor AY; Armién B; Pascale JM; Donnelly CA
    Am J Trop Med Hyg; 2020 Dec; 103(6):2429-2437. PubMed ID: 33124532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates.
    Dupuy LC; Richards MJ; Reed DS; Schmaljohn CS
    Vaccine; 2010 Oct; 28(46):7345-50. PubMed ID: 20851089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic diversity of Venezuelan alphaviruses and circulation of a Venezuelan equine encephalitis virus subtype IAB strain during an interepizootic period.
    Medina G; Garzaro DJ; Barrios M; Auguste AJ; Weaver SC; Pujol FH
    Am J Trop Med Hyg; 2015 Jul; 93(1):7-10. PubMed ID: 25940191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.
    Atasheva S; Kim DY; Frolova EI; Frolov I
    J Virol; 2015 Jan; 89(1):71-82. PubMed ID: 25320296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitors of Venezuelan Equine Encephalitis Virus Identified Based on Host Interaction Partners of Viral Non-Structural Protein 3.
    Bakovic A; Bhalla N; Alem F; Campbell C; Zhou W; Narayanan A
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macromolecular Synthesis Shutoff Resistance by Myeloid Cells Is Critical to IRF7-Dependent Systemic Interferon Alpha/Beta Induction after Alphavirus Infection.
    Bhalla N; Gardner CL; Downs SN; Dunn M; Sun C; Klimstra WB
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current strategic thinking for the development of a trivalent alphavirus vaccine for human use.
    Wolfe DN; Heppner DG; Gardner SN; Jaing C; Dupuy LC; Schmaljohn CS; Carlton K
    Am J Trop Med Hyg; 2014 Sep; 91(3):442-50. PubMed ID: 24842880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PERK Is Critical for Alphavirus Nonstructural Protein Translation.
    Dahal B; Lehman CW; Akhrymuk I; Bracci NR; Panny L; Barrera MD; Bhalla N; Jacobs JL; Dinman JD; Kehn-Hall K
    Viruses; 2021 May; 13(5):. PubMed ID: 34065980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.
    Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. β-d-
    Urakova N; Kuznetsova V; Crossman DK; Sokratian A; Guthrie DB; Kolykhalov AA; Lockwood MA; Natchus MG; Crowley MR; Painter GR; Frolova EI; Frolov I
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29167335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurological Sequelae Resulting from Encephalitic Alphavirus Infection.
    Ronca SE; Dineley KT; Paessler S
    Front Microbiol; 2016; 7():959. PubMed ID: 27379085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Homoseongomycin, a compound isolated from marine actinomycete bacteria K3-1, is a potent inhibitor of encephalitic alphaviruses.
    Lin SC; Lehman CW; Stewart AK; Panny L; Bracci N; Wright JLC; Paige M; Strangman WK; Kehn-Hall K
    Antiviral Res; 2021 Jul; 191():105087. PubMed ID: 33965437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Venezuelan equine encephalitis virus E1 protein interacts with PDIA6 and PDI inhibition reduces alphavirus production.
    Panny L; Akrhymuk I; Bracci N; Woodson C; Flor R; Elliott I; Zhou W; Narayanan A; Campbell C; Kehn-Hall K
    Antiviral Res; 2023 Apr; 212():105560. PubMed ID: 36822370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of a cell-based ELISA as a screening tool identifying anti-alphavirus small-molecule inhibitors.
    Spurgers KB; Hurt CR; Cohen JW; Eccelston LT; Lind CM; Lingappa VR; Glass PJ
    J Virol Methods; 2013 Oct; 193(1):226-31. PubMed ID: 23764417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.
    Pratt WD; Gibbs P; Pitt ML; Schmaljohn AL
    Vaccine; 1998; 16(9-10):1056-64. PubMed ID: 9682359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toll-like receptor 4 mediates blood-brain barrier permeability and disease in C3H mice during Venezuelan equine encephalitis virus infection.
    Hollidge BS; Cohen CA; Akuoku Frimpong J; Badger CV; Dye JM; Schmaljohn CS
    Virulence; 2021 Dec; 12(1):430-443. PubMed ID: 33487119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection.
    Calvert AE; Bennett SL; Hunt AR; Fong RH; Doranz BJ; Roehrig JT; Blair CD
    Virology; 2022 Jan; 565():13-21. PubMed ID: 34626907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.